Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.4452
Delayed Data
As of Feb 17
 +0.0053 / +1.20%
Today’s Change
0.26
Today|||52-Week Range
1.51
-30.16%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.44
Today’s open0.43
Day’s range0.43 - 0.45
Volume359,132
Average volume (3 months)774,403
Market cap$69.3M
Dividend yield--
Data as of 4:02pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.15%
P/E ratioNM
Price/Sales15.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LPCNLipocine Inc-0.05-1.31%
AGLEAeglea Bio Therapeut...+0.12+2.35%
NNVCNanoViricides Inc+0.01+0.89%
PULMPulmatrix Inc-0.19-4.52%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$13.2M
Annual profit (last year)-$27.6M
Net profit margin-213.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mike M. Goldberg
Chief Operating &
Financial Officer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts


Search for Jobs